Abstract
There are 51 known serotypes of human adenovirus, which are divided into subgroups (or species) A to F Table ). An additional serotype (52), which potentially constitutes a new species (G), has recently been reported after genomic sequencing and phylogenetic analysis of an isolate in the U.S.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adeyemia, O.A., Yeldandi, A.V., & Ison, M.G. (2008). Fatal adenovirus pneumonia in a person with AIDS and Burkitt lymphoma: a case report and review of the literature. AIDS Read, (18), 196–198, 201–202, 206–207.
Adeyi, O.A., Randhawa, P.A., Nalesnik, M.A., Ochoa, E.R., Abu-Elmagd, K.M., Demetris, A.J., & Wu, T. (2008). Posttransplant adenoviral enteropathy in patients with small bowel transplantation. Arch Pathol Lab Med, (132), 703–705.
Adrian, T., Schafer, G., Cooney, M.K., Fox, J.P., & Wigand, R. (1988). Persistent enteral infections with adenovirus types 1 and 2 in infants: no evidence of reinfection. Epidemiol Infect, (101), 503–509.
Anderson, E.J., Guzman-Cottrill, J.A., Kletzel, M., Thormann, K., Sullivan, C., Zheng, X., & Katz, B.Z. (2008). High-risk adenovirus-infected pediatric allogenic hematopoietic progenitor transplant recipients and preemptive cidofovir therapy. Pediatr Transplant, (12), 219–227.
Ardehali, H., Volmar, K., Roberts, C., Forman, M., & Becker, L.C. (2001). Fatal disseminated adenoviral infection in a renal transplant patient. Transplantation, (71), 998–999.
Baldwin, A., Kingman, H., Darville, M., Foot, A.B., Grier, D., Cornish, J.M., Goulden, N. et al. (2001). Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation. Bone Marrow Transplant, (26), 1333–1338.
Bateman, C.M., Kesson, A.M., & Shaw, P.J. (2006). Pancreatitis and adenoviral infection in children after blood and marrow transplantation. Bone Marrow Transplant, (38), 807–811.
Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S. et al. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science, (275), 1320–1323.
Berho, M., Torroella, M., Viciana, A., Weppler, D., Thompson, J., Nery, J., Tzakis, A., & Ruiz, P. (1998). Adenovirus enterocolitis in human small bowel transplants. Pediatr Transplant, (2), 277–282.
Bordigoni, P., Carret, A.S., Venard, V., Witz, F., & Le Faou, A. (2001). Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis, (32), 1290–1297.
Bruno, B., Gooley, T., Hackman, R.C., Davis, C., Corey, L., & Boeckh, M. (2003). Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biol Blood Marrow Transplant, (9), 341–352.
Cames, B., Rahier, J., Burtomboy, G., de Ville de Goyet, J., Reding, R., Lamy, M., Otte, J.B., & Sokal, E.M. (1992). Acute adenovirus hepatitis in liver transplant recipients. J Pediatr, (120), 33–37.
Carter, B.A., Karpen, S.J., Quiros-Tejeira, R.E., Chang, I.F., Clark, B.S., Demmler, G.J., Heslop, H.E. et al. (2002). Intravenous Cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient. Transplantation, (74), 1050–1052.
Cassano, W.F. (1991). Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant, (7), 247–248.
CDC. (2007). Acute respiratory disease associated with adenovirus serotype 14 – four states, 2006–2007. MMWR Morb Mortal Wkly Rep, (56), 1181–1184.
Chakrabarti, S., Collingham, K.E., Fegan, C.D., & Milligan, D.W. (1999). Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant, (23), 1209–1211.
Chakrabarti, S., Mautner, V., Osman, H., Collingham, K.E., Fegan, C.D., Klapper, P.E., Moss, P.A. et al. (2002). Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. Blood, (100), 1619–1627.
Claas, E.C., Schilham, M.W., de Brouwer, C.S., Hubacek, P., Echavarria, M., Lankester, A.C., van Tol, M.J. et al. (2005). Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients. J Clin Microbiol, (43), 1738–1744.
Dagan, R., Schwartz, R.H., Insel, R.A., & Menegus, M.A. (1984). Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody. Pediatr Infect Dis, (3), 246–251.
De Clercq, E. (2003). Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin Microbiol Rev, (16), 569–596.
De Clercq, E., Andrei, G., Balzarini, J., Leyssen, P., Naesens, L., Neyts, J., Pannecouque, C. et al. (2005). Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines. Nucleosides Nucleotides Nucleic Acids, (24), 331–341.
de Mezerville, M.H., Tellier, R., Richardson, S., Hebert, D., Doyle, J., & Allen, U. (2006). Adenoviral infections in pediatric transplant recipients: a hospital-based study. Pediatr Infect Dis J, (25), 815–818.
de Oliveira, C.B., Stevenson, D., LaBree, L., McDonnell, P.J., & Trousdale, M.D. (1996). Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model. Antiviral Res, (31), 165–172.
Doan, M.L., Mallory, G.B., Kaplan, S.L., Dishop, M.K., Schecter, M.G., McKenzie, E.D., Heinle, J.S. et al. (2007). Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. J Heart Lung Transplant, (26), 883–889.
Echavarria, M., Forman, M., Ticehurst, J., Dumler, J.S., & Charache, P. (1998). PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol, (36), 3323–3326.
Echavarria, M., Forman, M., van Tol, M.J., Vossen, J.M., Charache, P., & Kroes, A.C. (2001). Prediction of severe disseminated adenovirus infection by serum PCR. Lancet, (358), 384–385.
Edwards, K.M., Thompson, J., Paolini, J., & Wright, P.F. (1985). Adenovirus infections in young children. Pediatrics, (76), 420–424.
El-Sayed Zaki, M. & Abd-El Fatah, G.A. (2008). Rapid detection of oculopathogenic adenovirus in conjunctivitis. Curr Microbiol, (56), 105–109.
Emovon, O.E., Lin, A., Howell, D.N., Afzal, F., Baillie, M., Rogers, J., Baliga, P. et al. (2003). Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant, (18), 2436–2438.
Erard, V., Huang, M.L., Ferrenberg, J., Nguy, L., Stevens-Ayers, T.L., Hackman, R.C., Corey, L. et al. (2007). Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. Clin Infect Dis, (45), 958–965.
Espy, M.J., Hierholzer, J.C., & Smith, T.F. (1987). The effect of centrifugation on the rapid detection of adenovirus in shell vials. Am J Clin Pathol, (88), 358–360.
Feuchtinger, T., Lang, P., & Handgretinger, R. (2007). Adenovirus infection after allogeneic stem cell transplantation. Leuk Lymphoma, (48), 244–255.
Feuchtinger, T., Matthes-Martin, S., Richard, C., Lion, T., Fuhrer, M., Hamprecht, K., Handgretinger, R., Peters, C. et al. (2006). Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation. Br J Haematol, (134), 64–76.
Fianchi, L., Scardocci, A., Cattani, P., Tartaglione, T., & Pagano, L. (2003). Adenovirus meningoencephalitis in a patient with large B-cell lymphoma. Ann Hematol, (82), 313–315.
Flomenberg, P., Babbitt, J., Drobyski, W.R., Ash, R.C., Carrigan, D.R., Sedmak, G.V., McAuliffe, T. et al. (1994). Increasing incidence of adenovirus disease in bone marrow transplant recipients. J Infect Dis, (169), 775–781.
Fox, J.P., Brandt, C.D., Wassermann, F.E., Hall, C.E., Spigland, I., Kogon, A., & Elveback, L.R. (1969). The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. Am J Epidemiol, (89), 25–50.
Freymuth, F., Vabret, A., Cuvillon-Nimal, D., Simon, S., Dina, J., Legrand, L., Gouarin, S. et al. (2006). Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol, (78), 1498–1504.
Gardner, P.S. (1968). Virus infections and respiratory disease of childhood. Arch Dis Child, (43), 629–645.
Garnett, C.T., Erdman, D., Xu, W., & Gooding, L.R. (2002). Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. J Virol, (76), 10608–10616.
Greber, U.F., Suomalainen, M., Stidwill, R.P., Boucke, K., Ebersold, M.W., & Helenius, A. (1997). The role of the nuclear pore complex in adenovirus DNA entry. Embo J, (16), 5998–6007.
Greber, U.F., Willetts, M., Webster, P., & Helenius, A. (1993). Stepwise dismantling of adenovirus 2 during entry into cells. Cell, (75), 477–486.
Hale, G.A., Heslop, H.E., Krance, R.A., Brenner, M.A., Jayawardene, D., Srivastava, D.K., & Patrick, C.C. (1999). Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant, (23), 277–282.
Hatakeyama, N., Suzuki, N., Kudoh, T., Hori, T., Mizue, N., & Tsutsumi, H. (2003). Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant. Pediatr Infect Dis J, (22), 928–929.
Hedderwick, S.A., Greenson, J.K., McGaughy, V.R., & Clark, N.M. (1998). Adenovirus cholecystitis in a patient with AIDS. Clin Infect Dis, (26), 997–999.
Heemskerk, B., Lankester, A.C., van Vreeswijk, T., Beersma, M.F., Claas, E.C., Veltrop-Duits, L.A., Kroes, A.C. et al. (2005). Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipients. J Infect Dis, (191), 520–530.
Hierholzer, J.C. (1992). Adenoviruses in the immunocompromised host. Clin Microbiol Rev, (5), 262–274.
Hillenkamp, J., Reinhard, T., Ross, R.S., Bohringer, D., Cartsburg, O., Roggendorf, M., De Clercq, E. et al. (2001). Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Arch Ophthalmol, (119), 1487–1491.
Hillenkamp, J., Reinhard, T., Ross, R.S., Bohringer, D., Cartsburg, O., Roggendorf, M., De Clercq, E. et al. (2002). The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology, (109), 845–850.
Hoffman, J.A. (2006). Adenoviral disease in pediatric solid organ transplant recipients. Pediatr Transplant, (10), 17–25.
Hoffman, J.A., Shah, A.J., Ross, L.A., & Kapoor, N. (2001). Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation. Biol Blood Marrow Transplant, (7), 388–394.
Hofland, C.A., Eron, L.J., & Washecka, R.M. (2004). Hemorrhagic adenovirus cystitis after renal transplantation. Transplant Proc, (36), 3025–3027.
Hong, J.Y., Lee, H.J., Piedra, P.A., Choi, E.H., Park, K.H., Koh, Y.Y., & Kim, W.S. (2001). Lower respiratory tract infections due to adenovirus in hospitalized Korean children: epidemiology, clinical features, and prognosis. Clin Infect Dis, (32), 1423–1429.
Hough, R., Chetwood, A., Sinfield, R., Welch, J., & Vora, A. (2005). Fatal adenovirus hepatitis during standard chemotherapy for childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol, (27), 67–72.
Howard, D.S., Phillips, I.G., Reece, D.E., Munn, R.K., Henslee-Downey, J., Pittard, M., Barker, M. et al. (1999). Adenovirus infections in hematopoietic stem cell transplant recipients. Clin Infect Dis, (29), 1494–1501.
Hromas, R., Clark, C., Blanke, C., Tricot, G., Cornetta, K., Hedderman, A., & Broun, E.R. (1994a). Failure of ribavirin to clear adenovirus infections in T cell-depleted allogeneic bone marrow transplantation. Bone Marrow Transplant, (14), 663–664.
Hromas, R., Cornetta, K., Srour, E., Blanke, C., & Broun, E.R. (1994b). Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood, (84), 1689–1690.
Humar, A., Kumar, D., Mazzulli, T., Razonable, R.R., Moussa, G., Paya, C.V., Covington, E. et al. (2005). A surveillance study of adenovirus infection in adult solid organ transplant recipients. Am J Transplant, (5), 2555–2559.
Ison, M.G. (2006). Adenovirus infections in transplant recipients. Clin Infect Dis, (43), 331–339.
Jones, M.S., 2nd, Harrach, B., Ganac, R.D., Gozum, M.M., Dela Cruz, W.P., Riedel, B., Pan, C. et al (2007). New adenovirus species found in a patient presenting with gastroenteritis. J Virol, (81), 5978–5984.
Kalpoe, J.S., van der Heiden, P.L., Barge, R.M., Houtzager, S., Lankester, A.C., van Tol, M.J., & Kroes, A.C. (2007). Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning. Eur J Haematol, (78), 314–321.
Kampmann, B., Cubitt, D., Walls, T., Naik, P., Depala, M., Samarasinghe, S., Robson, D., Hassan, A. et al. (2005). Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation. Br J Haematol, (130), 595–603.
Kawakami, M., Ueda, S., Maeda, T., Karasuno, T., Teshima, H., Hiraoka, A., Nakamura, H. et al. (1997). Vidarabine therapy for virus-associated cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant, (20), 485–490.
Keswani, M. & Moudgil, A. (2007). Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient. Pediatr Transplant, (11), 568–571.
Kim, M.R., Lee, H.R., & Lee, G.M. (2000). Epidemiology of acute viral respiratory tract infections in Korean children. J Infect, (41), 152–158.
Kinchington, P.R., Araullo-Cruz, T., Vergnes, J.P., Yates, K., & Gordon, Y.J. (2002). Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir. Antiviral Res, (56), 73–84.
Kitabayashi, A., Hirokawa, M., Kuroki, J., Nishinari, T., Niitsu, H., & Miura, A.B. (1994). Successful vidarabine therapy for adenovirus type 11-associated acute hemorrhagic cystitis after allogeneic bone marrow transplantation. Bone Marrow Transplant, (14), 853–854.
Kojaoghlanian, T., Flomenberg, P., & Horwitz, M.S. (2003). The impact of adenovirus infection on the immunocompromised host. Rev Med Virol, (13), 155–171.
Koneru, B., Jaffe, R., Esquivel, C.O., Kunz, R., Todo, S., Iwatsuki, S., & Starzl, T.E. (1987). Adenoviral infections in pediatric liver transplant recipients. Jama, (258), 489–492.
Kurosaki, K., Miwa, N., Yoshida, Y., Kurokawa, M., Kurimoto, M., Endo, S., & Shiraki, K. (2004). Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis. Antivir Chem Chemother, (15), 281–285.
La Rosa, A.M., Champlin, R.E., Mirza, N., Gajewski, J., Giralt, S., Rolston, K.V., Raad, I. et al. (2001). Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis, (32), 871–876.
Lankester, A.C., Heemskerk, B., Claas, E.C., Schilham, M.W., Beersma, M.F., Bredius, R.G., van Tol, M.J. et al. (2004). Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis, (38), 1521–1525.
Lankester, A.C., van Tol, M.J., Claas, E.C., Vossen, J.M., & Kroes, A.C. (2002). Quantification of adenovirus DNA in plasma for management of infection in stem cell graft recipients. Clin Infect Dis, (34), 864–867.
Leen, A.M., Myers, G.D., Bollard, C.M., Huls, M.H., Sili, U., Gee, A.P., Heslop, H.E. et al. (2005). T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients. Ann N Y Acad Sci, (1062), 104–115.
Leen, A.M., Myers, G.D., Sili, U., Huls, M.H., Weiss, H., Leung, K.S., Carrum, G. et al. (2006). Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med, (12), 1160–1166.
Lenaerts, L., Verbeken, E., De Clercq, E., & Naesens, L. (2005). Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections. Antimicrob Agents Chemother, (49), 4689–4699.
Leruez-Ville, M., Chardin-Ouachee, M., Neven, B., Picard, C., Le Guinche, I., Fischer, A., Rouzioux, C. et al. (2006). Description of an adenovirus A31 outbreak in a paediatric haematology unit. Bone Marrow Transplant, (38), 23–28.
Leruez-Ville, M., Minard, V., Lacaille, F., Buzyn, A., Abachin, E., Blanche, S., Freymuth, F. et al. (2004). Real-time blood plasma polymerase chain reaction for management of disseminated adenovirus infection. Clin Infect Dis, (38), 45–52.
Leung, A.Y., Chan, M., Cheng, V.C., Yuen, K.Y., & Kwong, Y.L. (2005). Quantification of adenovirus in the lower respiratory tract of patients without clinical adenovirus-related respiratory disease. Clin Infect Dis, (40), 1541–1544.
Liles, W.C., Cushing, H., Holt, S., Bryan, C., & Hackman, R.C. (1993). Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant, (12), 409–412.
Lion, T., Baumgartinger, R., Watzinger, F., Matthes-Martin, S., Suda, M., Preuner, S., Futterknecht, B. et al. (2003). Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. Blood, (102), 1114–1120.
Ljungman, P., Ribaud, P., Eyrich, M., Matthes-Martin, S., Einsele, H., Bleakley, M., Machaczka, M. et al. (2003). Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant, (31), 481–486.
Louie, J.K., Kajon, A.E., Holodniy, M., Guardia-LaBar, L., Lee, B., Petru, A.M., Hacker, J.K. et al. (2008). Severe pneumonia due to adenovirus serotype 14: a new respiratory threat? Clin Infect Dis, (46), 421–425.
Mahafzah, A.M. & Landry, M.L. (1989). Evaluation of immunofluorescent reagents, centrifugation, and conventional cultures for the diagnosis of adenovirus infection. Diagn Microbiol Infect Dis, (12), 407–411.
Mann, D., Moreb, J., Smith, S., & Gian, V. (1998). Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogeneic bone marrow transplantation: a case report. J Infect, (36), 227–228.
Maslo, C., Girard, P.M., Urban, T., Guessant, S., & Rozenbaum, W. (1997). Ribavirin therapy for adenovirus pneumonia in an AIDS patient. Am J Respir Crit Care Med, (156), 1263–1264.
Matar, L.D., McAdams, H.P., Palmer, S.M., Howell, D.N., Henshaw, N.G., Davis, R.D., & Tapson, V.F. (1999). Respiratory viral infections in lung transplant recipients: radiologic findings with clinical correlation. Radiology, (213), 735–742.
McGrath, D., Falagas, M.E., Freeman, R., Rohrer, R., Fairchild, R., Colbach, C., & Snydman, D.R. (1998). Adenovirus infection in adult orthotopic liver transplant recipients: incidence and clinical significance. J Infect Dis, (177), 459–462.
Medina-Kauwe, L.K. (2003). Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Deliv Rev, (55), 1485–1496.
Mentel, R., Kinder, M., Wegner, U., von Janta-Lipinski, M., & Matthes, E. (1997). Inhibitory activity of 3’-fluoro-2’ deoxythymidine and related nucleoside analogues against adenoviruses in vitro. Antiviral Res, (34), 113–119.
Mentel, R. & Wegner, U. (2000). Evaluation of the efficacy of 2’,3’-dideoxycytidine against adenovirus infection in a mouse pneumonia model. Antiviral Res, (47), 79–87.
Michaels, M.G., Green, M., Wald, E.R., & Starzl, T.E. (1992). Adenovirus infection in pediatric liver transplant recipients. J Infect Dis, (165), 170–174.
Morfin, F., Dupuis-Girod, S., Mundweiler, S., Falcon, D., Carrington, D., Sedlacek, P., Bierings, M. et al. (2005). In vitro susceptibility of adenovirus to antiviral drugs is species-dependent. Antivir Ther, (10), 225–229.
Muller, W.J., Levin, M.J., Shin, Y.K., Robinson, C., Quinones, R., Malcolm, J., Hild, E. et al. (2005). Clinical and in vitro evaluation of cidofovir for treatment of adenovirus infection in pediatric hematopoietic stem cell transplant recipients. Clin Infect Dis, (41), 1812–1816.
Murphy, G.F., Wood, D.P., Jr., McRoberts, J.W., & Henslee-Downey, P.J. (1993). Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol, (149), 565–566.
Myerowitz, R.L., Stalder, H., Oxman, M.N., Levin, M.J., Moore, M., Leith, J.D., Gantz, N.M. et al. (1975). Fatal disseminated adenovirus infection in a renal transplant recipient. Am J Med, (59), 591–598.
Naesens, L., Lenaerts, L., Andrei, G., Snoeck, R., Van Beers, D., Holy, A., Balzarini, J. et al. (2005). Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chemother, (49), 1010–1016.
Nagafuji, K., Aoki, K., Henzan, H., Kato, K., Miyamoto, T., Eto, T., Nagatoshi, Y. et al. (2004). Cidofovir for treating adenoviral hemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplant, (34), 909–914.
Nebbia, G., Chawla, A., Schutten, M., Atkinson, C., Raza, M., Johnson, M., & Geretti, A. (2005). Adenovirus viraemia and dissemination unresponsive to antiviral therapy in advanced HIV-1 infection. Aids, (19), 1339–1340.
Nemerow, G.R., Cheresh, D.A., & Wickham, T.J. (1994). Adenovirus entry into host cells: a role for alpha(v) integrins. Trends Cell Biol, (4), 52–55.
Neofytos, D., Ojha, A., Mookerjee, B., Wagner, J., Filicko, J., Ferber, A., Dessain, S. et al. (2007). Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant, (13), 74–81.
Pacini, D.L., Collier, A.M., & Henderson, F.W. (1987). Adenovirus infections and respiratory illnesses in children in group day care. J Infect Dis, (156), 920–927.
Palmer, S.M., Jr., Henshaw, N.G., Howell, D.N., Miller, S.E., Davis, R.D., & Tapson, V.F. (1998). Community respiratory viral infection in adult lung transplant recipients. Chest, (113), 944–950.
Parizhskaya, M., Walpusk, J., Mazariegos, G., & Jaffe, R. (2001). Enteric adenovirus infection in pediatric small bowel transplant recipients. Pediatr Dev Pathol, (4), 122–128.
Pinchoff, R.J., Kaufman, S.S., Magid, M.S., Erdman, D.D., Gondolesi, G.E., Mendelson, M.H., Tane, K. et al. (2003). Adenovirus infection in pediatric small bowel transplantation recipients. Transplantation, (76), 183–189.
Rocholl, C., Gerber, K., Daly, J., Pavia, A.T., & Byington, C.L. (2004). Adenoviral infections in children: the impact of rapid diagnosis. Pediatrics, (113), e51–e56.
Romanowski, E.G., Yates, K.A., & Gordon, Y.J. (2001). Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model. Antiviral Res, (52), 275–280.
Rosario, R.F., Kimbrough, R.C., Van Buren, D.H., & Laski, M.E. (2006). Fatal adenovirus serotype-5 in a deceased-donor renal transplant recipient. Transpl Infect Dis, (8), 54–57.
Runde, V., Ross, S., Trenschel, R., Lagemann, E., Basu, O., Renzing-Kohler, K., Schaefer, U.W. et al. (2001). Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study. Bone Marrow Transplant, (28), 51–57.
Sabroe, I., McHale, J., Tait, D.R., Lynn, W.A., Ward, K.N., & Shaunak, S. (1995). Treatment of adenoviral pneumonitis with intravenous ribavirin and immunoglobulin. Thorax, (50), 1219–1220.
Safrin, S., Cherrington, J., & Jaffe, H.S. (1997). Clinical uses of cidofovir. Rev Med Virol, (7), 145–156.
Schilham, M.W., Claas, E.C., van Zaane, W., Heemskerk, B., Vossen, J.M., Lankester, A.C., Toes, R.E. et al. (2002). High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation. Clin Infect Dis, (35), 526–532.
Schowengerdt, K.O., Ni, J., Denfield, S.W., Gajarski, R.J., Radovancevic, B., Frazier, H.O., Demmler, G.J. et al. (1996). Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. J Heart Lung Transplant, (15), 111–123.
Seidel, M.G., Kastner, U., Minkov, M., & Gadner, H. (2003). IVIG treatment of adenovirus infection-associated macrophage activation syndrome in a two-year-old boy: case report and review of the literature. Pediatr Hematol Oncol, (20), 445–451.
Seidemann, K., Heim, A., Pfister, E.D., Koditz, H., Beilken, A., Sander, A., Melter, M. et al. (2004). Monitoring of adenovirus infection in pediatric transplant recipients by quantitative PCR: report of six cases and review of the literature. Am J Transplant, (4), 2102–2108.
Seth, P. (1994). Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J Virol, (68), 1204–1206.
Shields, A.F., Hackman, R.C., Fife, K.H., Corey, L., & Meyers, J.D. (1985). Adenovirus infections in patients undergoing bone-marrow transplantation. N Engl J Med, (312), 529–533.
Shirali, G.S., Ni, J., Chinnock, R.E., Johnston, J.K., Rosenthal, G.L., Bowles, N.E., & Towbin, J.A. (2001). Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med, (344), 1498–1503.
Sivaprakasam, P., Carr, T.F., Coussons, M., Khalid, T., Bailey, A.S., Guiver, M., Mutton, K.J. et al. (2007). Improved outcome from invasive adenovirus infection in pediatric patients after hemopoietic stem cell transplantation using intensive clinical surveillance and early intervention. J Pediatr Hematol Oncol, (29), 81–85.
Steiner, I., Aebi, C., Ridolfi Luthy, A., Wagner, B., & Leibundgut, K. (2008). Fatal adenovirus hepatitis during maintenance therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer, (50), 647–649.
Symeonidis, N., Jakubowski, A., Pierre-Louis, S., Jaffe, D., Pamer, E., Sepkowitz, K., O’Reilly, R.J. et al. (2007). Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. Transpl Infect Dis, (9), 108–113.
Uchio, E., Fuchigami, A., Kadonosono, K., Hayashi, A., Ishiko, H., Aoki, K., & Ohno, S. (2007). Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol, (245), 1319–1325.
van Tol, M.J., Kroes, A.C., Schinkel, J., Dinkelaar, W., Claas, E.C., Jol-van der Zijde, C.M. et al. (2005). Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery. Bone Marrow Transplant, (36), 39–50.
Wallot, M.A., Dohna-Schwake, C., Auth, M., Nadalin, S., Fiedler, M., Malago, M., Broelsch, C. et al. (2006). Disseminated adenovirus infection with respiratory failure in pediatric liver transplant recipients: impact of intravenous cidofovir and inhaled nitric oxide. Pediatr Transplant, (10), 121–127.
Walls, T., Hawrami, K., Ushiro-Lumb, I., Shingadia, D., Saha, V., & Shankar, A.G. (2005). Adenovirus infection after pediatric bone marrow transplantation: is treatment always necessary? Clin Infect Dis, (40), 1244–1249.
Walls, T., Shankar, A.G., & Shingadia, D. (2003). Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infect Dis, (3), 79–86.
Wickham, T.J., Mathias, P., Cheresh, D.A., & Nemerow, G.R. (1993). Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell, (73), 309–319.
Wigger, H.J. & Blanc, W.A. (1966). Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia. N Engl J Med, (275), 870–874.
Wong, S., Pabbaraju, K., Pang, X.L., Lee, B.E., & Fox, J.D. (2008). Detection of a broad range of human adenoviruses in respiratory tract samples using a sensitive multiplex real-time PCR assay. J Med Virol, (80), 856–865.
Wulffraat, N.M., Geelen, S.P., van Dijken, P.J., de Graeff-Meeder, B., Kuis, W., & Boven, K. (1995). Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin. Transplantation, (59), 927.
Yusuf, U., Hale, G.A., Carr, J., Gu, Z., Benaim, E., Woodard, P., Kasow, K.A. et al. (2006). Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation, (81), 1398–1404.
Ziring, D., Tran, R., Edelstein, S., McDiarmid, S.V., Gajjar, N., Cortina, G., Vargas, J. et al. (2005). Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation, (79), 702–709.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tebruegge, M., Curtis, N. (2010). Adenovirus Infection in the Immunocompromised Host. In: Finn, A., Curtis, N., Pollard, A. (eds) Hot Topics in Infection and Immunity in Children VI. Advances in Experimental Medicine and Biology, vol 659. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0981-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0981-7_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0980-0
Online ISBN: 978-1-4419-0981-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)